Construction and characterization of virus-like particles: A review

Molecular Biotechnology

Volumn 53, Issue 1, 2013, Pages 92-107

  Zeltins, Andris ^a  

^a LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

Author keywords

Cloning; Expression system; Nanoparticle; Self assembly; Vaccine; Virus

Indexed keywords

CLINICAL STUDY; EXPRESSION SYSTEM; MEDICAL PRODUCTS; PURIFICATION PROCEDURES; STRUCTURAL GENE; VACCINOLOGY; VIRUS-LIKE PARTICLES;

CLONING; NANOPARTICLES; NUCLEIC ACIDS; SELF ASSEMBLY; VACCINES;

VIRUSES;

NUCLEIC ACID;

GENE EXPRESSION SYSTEM; MAMMAL CELL; MEDICAL LITERATURE; MOLECULAR CLONING; NONHUMAN; PURIFICATION; REVIEW; VIRUS CELL INTERACTION; VIRUS LIKE AGENT; VIRUS MORPHOLOGY;

ANIMALS; CELL-FREE SYSTEM; CLONING, MOLECULAR; ESCHERICHIA COLI; GENES, VIRAL; GENETIC THERAPY; GENETIC VECTORS; HUMANS; INSECTS; PLANTS; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; VACCINES, VIRUS-LIKE PARTICLE; VIRAL VACCINES; VIRUSES;

EID: 84871650149     PISSN: 10736085     EISSN: 15590305     Source Type: Journal    
DOI: 10.1007/s12033-012-9598-4     Document Type: Review

References (158)

1. Pumpens, P., & Grens, E. (2002). Artificial genes for chimeric virus-like particles. In Y. E. Khudyakov & H. A. Fields (Eds.), Artificial DNA: Methods and applications (pp. 249-327). Boca Raton: CRC Press.
2. Pumpens, P., Ulrich, R., Sasnauskas, K., Kazaks, A., Ose, V., & Grens, E. (2009). Construction of novel vaccines on the basis of the virus-like particles: Hepatitis B virus proteins as vaccine carriers. In Y. E. Khudyakov (Ed.), Medicinal protein engineering (pp. 205-248). Boca Raton: CRC Press.
3. Frazer, I. H. (2004). Prevention of cervical cancer through papillomavirus vaccination. Nature Reviews Immunology, 4, 46-54. (Pubitemid 38084131)
4. Liu, F., Ge, S., Li, L., Wu, X., Liu, Z., & Wang, Z. (2012). Virus-like particles: Potential veterinary vaccine immunogens. Research in Veterinary Science, 93, 553-559.
5. Roldão, A., Mellado, M. C., Castilho, L. R., Carrondo, M. J., & Alves, P. M. (2010). Virus-like particles in vaccine development. Expert Review of Vaccines, 9, 1149-1176.
6. Bachmann, M. F., & Zinkernagel, R. M. (1997). Neutralizing antiviral B cell responses. Annual Review of Immunology, 15, 235-270. (Pubitemid 27169281)
7. Brun, A., Bárcena, J., Blanco, E., Borrego, B., Dory, D., Escribano, J. M., et al. (2011). Current strategies for subunit and genetic viral veterinary vaccine development. Virus Research, 157, 1-12.
8. Bachmann, M. F., & Dyer, M. R. (2004). Therapeutic vaccination for chronic diseases: A new class of drugs in sight. Nature Reviews Drug Discovery, 3, 81-88. (Pubitemid 38088700)
9. Bachmann, M. F., Rohrer, U. H., Kündig, T. M., Bürki, K., Hengartner, H., & Zinkernagel, R. M. (1993). The influence of antigen organization on B cell responsiveness. Science, 262, 1448-1451. (Pubitemid 24035067)
10. Lamarre, B., & Ryadnov, M. G. (2011). Self-assembling viral mimetics: One long journey with short steps. Macromolecular Bioscience, 8, 503-513.
11. Seow, Y., & Wood, M. J. (2009). Biological gene delivery vehicles: Beyond viral vectors. Molecular Therapy, 17, 767-777.
12. Soto, C. M., & Ratna, B. R. (2010). Virus hybrids as nanomaterials for biotechnology. Current Opinion in Biotechnology, 21, 426-438.
13. Lee, L. A., Niu, Z., & Wang, Q. (2009). Viruses and virus-like protein assemblies - chemically programmable nanoscale building blocks. Nano Research, 2, 349-364.
14. Pattenden, L. K., Middelberg, A. P., Niebert, M., & Lipin, D. I. (2005). Towards the preparative and large-scale precision manufacture of virus-like particles. Trends in Biotechnology, 23, 523-529. (Pubitemid 41317916)
15. Hoenen, T., Groseth, A., de Kok-Mercado, F., Kuhn, J. H., & Wahl-Jensen, V. (2011). Minigenomes, transcription and replication competent virus-like particles and beyond: Reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses. Antiviral Research, 91, 195-208.
16. Saccardo, P., Villaverde, A., & González-Montalbán, N. (2009). Peptide-mediated DNA condensation for non-viral gene therapy. Biotechnology Advances, 27, 432-438.
17. Burrell, C. J., MacKay, P., Greenaway, P. J., Hofschneider, P. H., & Murray, K. (1979). Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322. Nature, 279, 43-47. (Pubitemid 9157566)
18. Valenzuela, P., Medina, A., Rutter, W. J., Ammerer, G., & Hall, B. D. (1982). Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature, 298, 347-350. (Pubitemid 12044287)
19. Haynes, J. R., Cunningham, J., von Seefried, A., Lennick, M., Garvin, R. T., & Shen, S. H. (1986). Development of a genetically-engineered, candidate polio vaccine employing the selfassembling properties of the tobacco mosaic virus coat protein. Biotechnology, 4, 637-641. (Pubitemid 17218669)
20. Cohen, B. J., & Richmond, J. E. (1982). Electron microscopy of hepatitis B core antigen synthesized in E. coli. Nature, 296, 677-678. (Pubitemid 12089078)
21. Chuan, Y. P., Lua, L. H., & Middelberg, A. P. (2008). High-level expression of soluble viral structural protein in Escherichia coli. Journal of Biotechnology, 20, 64-71.
22. Sánchez-Rodríguez, S. P., Münch-Anguiano, L., Echeverría, O., Vázquez-Nin, G., Mora-Pale, M., Dordick, J. S., et al. (2012). Human parvovirus B19 virus-like particles: In vitro assembly and stability. Biochimie, 94, 870-878.
23. Zhao, X., Fox, J. M., Olson, N. H., Baker, T. S., & Young, M. J. (1995). In vitro assembly of cowpea chlorotic mottle virus from coat protein expressed in Escherichia coli and in vitro-transcribed viral cDNA. Virology, 10, 486-494.
24. Xu, Y., Ye, J., Liu, H., Cheng, E., Yang, Y., Wang, W., et al. (2008). DNA-templated CMV viral capsid proteins assemble into nanotubes. Chemical Communications, 1, 49-51. (Pubitemid 350264894)
25. Hwang, D. J., Roberts, I. M., & Wilson, T. M. (1994). Expression of tobacco mosaic virus coat protein and assembly of pseudovirus particles in Escherichia coli. Proceedings of the National Academy of Science of the United States of America, 91, 9067-9071.
26. Hou, L., Wu, H., Xu, L., & Yang, F. (2009). Expression and self-assembly of virus-like particles of infectious hypodermal and hematopoietic necrosis virus in Escherichia coli. Archives of Virology, 154, 547-553.
27. Kalnciema, I., Skrastina, D., Ose, V., Pumpens, P. & Zeltins, A. (2011). Potato virus Y-like particles as a new carrier for the presentation of foreign protein stretches. Molecular Biotechnology. doi: 10.1007/s12033-011- 9480-9.
28. Brown, S. D., Fiedler, J. D., & Finn, M. G. (2009). Assembly of hybrid bacteriophage Qbeta virus-like particles. Biochemistry, 48, 11155-11157.
29. Rogel, A., Benvenisti, L., Sela, I., Edelbaum, O., Tanne, E., Shachar, Y., et al. (2003). Vaccination with E. coli recombinant empty viral particles of infectious bursal disease virus (IBDV) confer protection. Virus Genes, 27, 169-175. (Pubitemid 37255567)
30. Hammond, R. W., & Hammond, J. (2010). Maize rayado fino virus capsid proteins assemble into virus-like particles in Escherichia coli. Virus Research, 147, 208-215.
31. Chen, X. S., Garcea, R. L., Goldberg, I., Casini, G., & Harrison, S. C. (2000). Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Molecular Cell, 5, 557-567.
32. Middelberg, A. P., Rivera-Hernandez, T., Wibowo, N., Lua, L. H., Fan, Y., Magor, G., et al. (2011). A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines. Vaccine, 29, 7154-7162.
33. Lee, C. D., Yan, Y. P., Liang, S. M., & Wang, T. F. (2009). Production of FMDV virus-like particles by a SUMO fusion protein approach in Escherichia coli. Journal of Biomedical Science, 16, 69.
34. Ju, H., Wei, N., Wang, Q., Wang, C., Jing, Z., Guo, L., et al. (2011). Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose. Biochemical and Biophysical Research Communications, 409, 131-136.
35. Cortes-Perez, N. G., Kharrat, P., Langella, P., & Bermúdez-Humarán, L. G. (2009). Heterologous production of human papillomavirus type-16 L1 protein by a lactic acid bacterium. BMC Research Notes, 2, 167.
36. Phelps, J. P., Dao, P., Jin, H., & Rasochova, L. (2007). Expression and self-assembly of cowpea chlorotic mottle virus-like particles in Pseudomonas fluorescens. Journal of Biotechnology, 128, 290-296. (Pubitemid 46074195)
37. Legendre, D., & Fastrez, J. (2005). Production in Saccharomyces cerevisiae of MS2 virus-like particles packaging functional heterologous mRNAs. Journal of Biotechnology, 117, 183-194. (Pubitemid 40488708)
38. Freivalds, J., Dislers, A., Ose, V., Skrastina, D., Cielens, I., Pumpens, P., et al. (2006). Assembly of bacteriophage Qbeta virus-like particles in yeast Saccharomyces cerevisiae and Pichia pastoris. Journal of Biotechnology, 123, 297-303. (Pubitemid 44294583)
39. Freivalds, J., Rūmnieks, J., Ose, V., Renhofa, R., & Kazāks, A. (2008). High-level expression and purification of bacteriophage GA virus-like particles from yeast Saccharomyces cerevisiae and Pichia pastoris. Acta Universitatis Latviensis, 745, 75-85.
40. Burns, N. R., Saibil, H. R., White, N. S., Pardon, J. F., Timmins, P. A., Richardson, S. M., et al. (1992). Symmetry, flexibility and permeability in the structure of yeast retrotransposon virus-like particles. EMBO Journal, 11, 1155-1164.
41. Powilleit, F., Breinig, T., & Schmitt, M. J. (2007). Exploiting the yeast L-A viral capsid for the in vivo assembly of chimeric VLPs as platform in vaccine development and foreign protein expression. PLoS ONE, 2(5), e415.
42. Krol, M. A., Olson, N. H., Tate, J., Johnson, J. E., Baker, T. S., & Ahlquist, P. (1999). RNA-controlled polymorphism in the in vivo assembly of 180-subunit and 120-subunit virions from a single capsid protein. Proceedings of the National Academy of Science of the United States of America, 96, 13650-13655.
43. Brumfield, S., Willits, D., Tang, L., Johnson, J. E., Douglas, T., & Young, M. (2004). Heterologous expression of the modified coat protein of Cowpea chlorotic mottle bromovirus results in the assembly of protein cages with altered architectures and function. Journal of General Virology, 85, 1049-1053. (Pubitemid 38489570)
44. Freivalds, J., Dislers, A., Ose, V., Pumpens, P., Tars, K., & Kazaks, A. (2011). Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris. Protein Expression and Purification, 75, 218-224.
45. Hofmann, K. J., Cook, J. C., Joyce, J. G., Brown, D. R., Schultz, L. D., George, H. A., et al. (1995). Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae. Virology, 209, 506-518.
46. Juozapaitis, M., Serva, A., Kucinskaite, I., Zvirbliene, A., Slibinskas, R., Staniulis, J., et al. (2007). Generation of menangle virus nucleocapsid-like particles in yeast Saccharomyces cerevisiae. Journal of Biotechnology, 130, 441-447. (Pubitemid 47021242)
47. Janowicz, Z. A., Melber, K., Merckelbach, A., Jacobs, E., Harford, N., Comberbach, M., et al. (1991). Simultaneous expression of the S and L surface antigens of hepatitis B, and formation of mixed particles in the methylotrophic yeast, Hansenula polymorpha. Yeast, 7, 431-443.
48. Rodríguez-Limas, W. A., Tyo, K. E., Nielsen, J., Ramírez, O. T., & Palomares, L. A. (2011). Molecular and process design for rotavirus-like particle production in Saccharomyces cerevisiae. Microbial Cell Factories, 10, 33.
49. Morikawa, Y., Goto, T., Yasuoka, D., Momose, F., & Matano, T. (2007). Defect of human immunodeficiency virus type 2 Gag assembly in Saccharomyces cerevisiae. Journal of Virology, 81, 9911-9921. (Pubitemid 350067694)
50. Lünsdorf, H., Gurramkonda, C., Adnan, A., Khanna, N., & Rinas, U. (2011). Virus-like particle production with yeast: Ultrastructural and immunocytochemical insights into Pichia pastoris producing high levels of the hepatitis B surface antigen. Microbial Cell Factories, 10, 48.
51. Kato, T., Deo, V. K., & Park, E. Y. (2012). Functional virus-like particles production using silkworm and their application in life science. Journal of Biotechnology & Biomaterials, S9, 001.
52. Vicente, T., Roldão, A., Peixoto, C., Carrondo, M. J., & Alves, P. M. (2011). Large-scale production and purification of VLP-based vaccines. Journal of Invertebrate Pathology, 107, S42-S48.
53. Sokolenko, S., George, S., Wagner, A., Tuladhar, A., Andrich, J. M., & Aucoin, M. G. (2012). Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: Benefits and drawbacks. Biotechnology Advances, 30, 766-781.
54. Tatman, J. D., Preston, V. G., Nicholson, P., Elliott, R. M., & Rixon, F. J. (1994). Assembly of herpes simplex virus type 1 capsids using a panel of recombinant baculoviruses. Journal of General Virology, 75(Pt 5), 1101-1113. (Pubitemid 24143155)
55. Pushko, P., Tumpey, T. M., Bu, F., Knell, J., Robinson, R., & Smith, G. (2005). Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine, 23, 5751-5759. (Pubitemid 41668881)
56. Latham, T., & Galarza, J. M. (2001). Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. Journal of Virology, 75, 6154-6165. (Pubitemid 32553146)
57. Metz, S. W., Feenstra, F., Villoing, S., van Hulten, M. C., van Lent, J. W., Koumans, J., et al. (2011). Low temperature-dependent salmonid alphavirus glycoprotein processing and recombinant virus-like particle formation. PLoS ONE, 6(10), e25816.
58. Saunders, K., Sainsbury, F., & Lomonossoff, G. P. (2009). Efficient generation of cowpea mosaic virus empty virus-like particles by the proteolytic processing of precursors in insect cells and plants. Virology, 393, 329-337.
59. Chung, Y. C., Huang, J. H., Lai, C. W., Sheng, H. C., Shih, S. R., Ho, M. S., et al. (2006). Expression, purification and characterization of enterovirus-71 virus-like particles. World Journal of Gastroenterology, 12, 921-927.
60. Molinari, P., Peralta, A., & Taboga, O. (2008). Production of rotavirus-like particles in Spodoptera frugiperda larvae. Journal of Virological Methods, 147, 364-367.
61. Yao, L., Wang, S., Su, S., Yao, N., He, J., Peng, L., et al. (2012). Construction of a baculovirus-silkworm multigene expression system and its application on producing virus-like particles. PLoS ONE, 7(3), e32510.
62. Rybicki, E. (2010). Plant-made vaccines for humans and animals. Plant Biotechnology Journal, 8, 620-637.
63. Zeltins, A. (2009). Plant virus biotechnology platforms for expression of medicinal proteins. In Y. E. Khudyakov (Ed.), Medicinal protein engineering (pp. 481-517). Boca Raton: CRC Press.
64. Lai, H., & Chen, Q. (2012). Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations. Plant Cell Reports, 31(3), 573-584.
65. Tacket, C. O. (2009). Plant-based oral vaccines: Results of human trials. Current Topics in Microbiology and Immunology, 332, 103-117.
66. Gomez-Lim, M. A. (2009). Production of pharmaceutical compounds in plants. In Y. E. Khudyakov (Ed.), Medicinal protein engineering (pp. 445-479). Boca Raton: CRC Press.
67. Mason, H. S., & Herbst-Kralovetz, M. M. (2012). Plant-derived antigens as mucosal vaccines. Current Topics in Microbiology and Immunology, 354, 101-120.
68. Gleba, Y., Klimyuk, V., & Marillonnet, S. (2007). Viral vectors for the expression of proteins in plants. Current Opinion in Biotechnology, 18, 134-141. (Pubitemid 46575232)
69. Lomonossoff, G. P. & Evans, D.J. (2011). Applications of Plant Viruses in Bionanotechnology. Current Topics in Microbiology and Immunology. doi: 10.1007/82-2011-184.
70. Wurm, F. M. (2004). Production of recombinant protein therapeutics in cultivated mammalian cells. Nature Biotechnology, 22, 1393-1398. (Pubitemid 39482858)
71. Walsh, G. (2006). Biopharmaceutical benchmarks 2006. Nature Biotechnology, 24, 769-776. (Pubitemid 44086612)
72. Wu, C. Y., Yeh, Y. C., Yang, Y. C., Chou, C., Liu, M. T., Wu, H. S., et al. (2010). Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus. PLoS ONE, 5(3), e9784.
73. Mena, I., Vivo, A., Pérez, E., & Portela, A. (1996). Rescue of a synthetic chloramphenicol acetyltransferase RNA into influenza virus-like particles obtained from recombinant plasmids. Journal of Virology, 70, 5016-5024. (Pubitemid 26240671)
74. Akahata, W., Yang, Z. Y., Andersen, H., Sun, S., Holdaway, H. A., Kong, W. P., et al. (2010). A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nature Medicine, 16, 334-338.
75. Carlson, E. D., Gan, R., Hodgman, C. E. & Jewett, M. C. (2011). Cell-free protein synthesis: Applications come of age. Biotechnology Advances. doi: 10.1016/j.biotechadv.2011.09.016.
76. Smith, M. T., Varner, C. T., Bush, D. B., & Bundy, B. C. (2012). The incorporation of the A2 protein to produce novel Qβ virus-like particles using cell-free protein synthesis. Biotechnology Progress, 28, 549-555.
77. Bundy, B. C., & Swartz, J. R. (2011). Efficient disulfide bond formation in virus-like particles. Journal of Biotechnology, 154, 230-239.
78. Patel, K. G., & Swartz, J. R. (2011). Surface functionalization of virus-like particles by direct conjugation using azide-alkyne click chemistry. Bioconjugate Chemistry, 22, 376-387.
79. Vicente, T., Mota, J. P., Peixoto, C., Alves, P. M., & Carrondo, M. J. (2011). Rational design and optimization of downstream processes of virus particles for biopharmaceutical applications: Current advances. Biotechnology Advances, 29, 869-878.
80. Cull, M., & McHenry, C. S. (1990). Preparation of extracts from prokaryotes. Methods in Enzymology, 182, 147-153. (Pubitemid 20154385)
81. Salazar, O., & Asenjo, J. A. (2007). Enzymatic lysis of microbial cells. Biotechnology Letters, 29, 985-994. (Pubitemid 46800623)
82. Hardy, E., Martínez, E., Diago, D., Díaz, R., González, D., & Herrera, L. (2000). Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris. Journal of Biotechnology, 77, 157-167. (Pubitemid 30055332)
83. Zhao, Q., Modis, Y., High, K., Towne, V., Meng, Y., Wang, Y., et al. (2012). Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity. Virology Journal, 9, 52.
84. Lewis, G. D., & Metcalf, T. G. (1988). Polyethylene glycol precipitation for recovery of pathogenic viruses, including hepatitis A virus and human rotavirus, from oyster, water, and sediment samples. Applied and Environmental Microbiology, 54, 1983-1988.
85. Birnbaum, F., & Nassal, M. (1990). Hepatitis B virus nucleocapsid assembly: Primary structure requirements in the core protein. Journal of Virology, 64, 3319-3330. (Pubitemid 20219537)
86. Wróbel, B., Yosef, Y., Oppenheim, A. B., & Oppenheim, A. (2000). Production and purification of SV40 major capsid protein (VP1) in Escherichia coli strains deficient for the GroELS chaperone machine. Journal of Biotechnology, 84, 285-289.
87. White, L. J., Hardy, M. E., & Estes, M. K. (1997). Biochemical characterization of a smaller form of recombinant Norwalk virus capsids assembled in insect cells. Journal of Virology, 71, 8066-8072. (Pubitemid 27391767)
88. Branco, L. M., Grove, J. N., Geske, F. J., Boisen, M. L., Muncy, I. J., Magliato, S. A., et al. (2010). Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever. Virology Journal, 7, 279.
89. Porterfield, J. Z., & Zlotnick, A. (2010). A simple and general method for determining the protein and nucleic acid content of viruses by UV absorbance. Virology, 407, 281-288.
90. Goodridge, L., Goodridge, C., Wu, J., Griffiths, M., & Pawliszyn, J. (2004). Isoelectric point determination of norovirus virus-like particles by capillary isoelectric focusing with whole column imaging detection. Analytical Chemistry, 76, 48-52. (Pubitemid 38040631)
91. Hewat, E. A., Booth, T. F., Loudon, P. T., & Roy, P. (1992). Three-dimensional reconstruction of baculovirus expressed bluetongue virus core-like particles by cryo-electron microscopy. Virology, 189, 10-20.
92. Fuller, S. D., Wilk, T., Gowen, B. E., Kräusslich, H. G., & Vogt, V. M. (1997). Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle. Current Biology, 7, 729-738. (Pubitemid 27441827)
93. Yu, X., Qiao, M., Atanasov, I., Hu, Z., Kato, T., Liang, T. J., et al. (2007). Cryo-electron microscopy and three-dimensional reconstructions of hepatitis C virus particles. Virology, 367, 126-134. (Pubitemid 47418928)
94. Voss, J. E., Vaney, M. C., Duquerroy, S., Vonrhein, C., Girard-Blanc, C., Crublet, E., et al. (2010). Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature, 468, 709-712.
95. Kumar, S., Ochoa, W., Singh, P., Hsu, C., Schneemann, A., Manchester, M., et al. (2009). Tomato bushy stunt virus (TBSV), a versatile platform for polyvalent display of antigenic epitopes and vaccine design. Virology, 388, 185-190.
96. Crowther, R. A. (2010). From envelopes to atoms: The remarkable progress of biological electron microscopy. Advances in Protein Chemistry and Structural Biology, 81, 1-32.
97. Goldsmith, C. S., & Miller, S. E. (2009). Modern uses of electron microscopy for detection of viruses. Clinical Microbiology Reviews, 22, 552-563.
98. Persson, M., Tars, K., & Liljas, L. (2008). The capsid of the small RNA phage PRR1 is stabilized by metal ions. Journal of Molecular Biology, 383, 914-922.
99. Plevka, P., Kazaks, A., Voronkova, T., Kotelovica, S., Dishlers, A., Liljas, L., et al. (2009). The structure of bacteriophage phiCb5 reveals a role of the RNA genome and metal ions in particle stability and assembly. Journal of Molecular Biology, 391, 635-647.
100. Savithri, H. S., & Murthy, M. R. N. (2010). Structure and assembly of Sesbania mosaic virus. Current Science, 98, 346-351.
101. Lane, S. W., Dennis, C. A., Lane, C. L., Trinh, C. H., Rizkallah, P. J., Stockley, P. G., et al. (2011). Construction and crystal structure of recombinant STNV capsids. Journal of Molecular Biology, 413, 41-50.
102. Ausar, S. F., Foubert, T. R., Hudson, M. H., Vedvick, T. S., & Middaugh, C. R. (2006). Conformational stability and disassembly of Norwalk virus-like particles. Effect of pH and temperature. Journal of Biological Chemistry, 281, 19478-19488. (Pubitemid 44035452)
103. Cuellar, J. L., Meinhoevel, F., Hoehne, M., & Donath, E. (2010). Size and mechanical stability of norovirus capsids depend on pH: A nanoindentation study. Journal of General Virology, 91, 2449-2456.
104. Rumnieks, J., Ose, V., Tars, K., Dislers, A., Strods, A., Cielens, I., et al. (2009). Assembly of mixed rod-like and spherical particles from group I and II RNA bacteriophage coat proteins. Virology, 391, 187-194.
105. Lang, R., Winter, G., Vogt, L., Zurcher, A., Dorigo, B., & Schimmele, B. (2009). Rational design of a stable, freeze-dried virus-like particle-based vaccine formulation. Drug Development and Industrial Pharmacy, 35, 83-97.
106. Kissmann, J., Joshi, S. B., Haynes, J. R., Dokken, L., Richardson, C., & Middaugh, C. R. (2011). H1N1 influenza virus-like particles: Physical degradation pathways and identification of stabilizers. Journal of Pharmaceutical Sciences, 100, 634-645.
107. Bragard, C., Duncan, G. H., Wesley, S. V., Naidu, R. A., & Mayo, M. A. (2000). Virus-like particles assemble in plants and bacteria expressing the coat protein gene of Indian peanut clump virus. Journal of General Virology, 81, 267-272. (Pubitemid 30047930)
108. Lokesh, G. L., Gowri, T. D., Satheshkumar, P. S., Murthy, M. R., & Savithri, H. S. (2002). A molecular switch in the capsid protein controls the particle polymorphism in an icosahedral virus. Virology, 292, 211-223. (Pubitemid 34920541)
109. Hema, M., Subba Reddy, C. V., Savithri, H. S., & Sreenivasulu, P. (2008). Assembly of recombinant coat protein of sugarcane streak mosaic virus into potyvirus-like particles. Indian Journal of Experimental Biology, 46, 793-796.
110. Routh, A., Domitrovic, T., & Johnson, J. E. (2012). Host RNAs, including transposons, are encapsidated by a eukaryotic single-stranded RNA virus. Proceedings of the National Academy of Science of the United States of America, 109, 1907-1912.
111. Bunka, D. H., Lane, S. W., Lane, C. L., Dykeman, E. C., Ford, R. J., Barker, A. M., et al. (2011). Degenerate RNA packaging signals in the genome of Satellite Tobacco Necrosis Virus: Implications for the assembly of a T = 1 capsid. Journal of Molecular Biology, 413, 51-65.
112. Kaczmarczyk, S. J., Sitaraman, K., Young, H. A., Hughes, S. H., & Chatterjee, D. K. (2011). Protein delivery using engineered virus-like particles. Proceedings of the National Academy of Science of the United States of America, 108, 16998-17003.
113. Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003). Progress and problems with the use of viral vectors for gene therapy. Nature Reviews Genetics, 4, 346-358. (Pubitemid 36538359)
114. Storni, T., Ruedl, C., Schwarz, K., Schwendener, R. A., Renner, W. A., & Bachmann, M. F. (2004). Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects. Journal of Immunology, 172, 1777-1785. (Pubitemid 38116826)
115. Ng, B. C., Chan, S. T., Lin, J., & Tolbert, S. H. (2011). Using polymer conformation to control architecture in semiconducting polymer/viral capsid assemblies. ACS Nano, 5, 7730-7738.
116. Newman, M., Chua, P. K., Tang, F. M., Su, P. Y., & Shih, C. (2009). Testing an electrostatic interaction hypothesis of hepatitis B virus capsid stability by using an in vitro capsid disassembly/reassembly system. Journal of Virology, 83, 10616-10626.
117. Fang, C. Y., Lin, P. Y., Ou, W. C., Chen, P. L., Shen, C. H., Chang, D., et al. (2012). Analysis of the size of DNA packaged by the human JC virus-like particle. Journal of Virological Methods, 182, 87-92.
118. Kaltgrad, E., O'Reilly, M. K., Liao, L., Han, S., Paulson, J. C., & Finn, M. G. (2008). On-virus construction of polyvalent glycan ligands for cell-surface receptors. Journal of the American Chemical Society, 130, 4578-4579. (Pubitemid 351500082)
119. Strable, E., & Finn, M. G. (2009). Chemical modification of viruses and virus-like particles. Current Topics in Microbiology and Immunology, 327, 1-21.
120. Spohn, G., Guler, R., Johansen, P., Keller, I., Jacobs, M., Beck, M., et al. (2007). A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosis. Journal of Immunology, 178, 7450-7457. (Pubitemid 46847473)
121. Bachmann, M. F., & Jennings, G. T. (2011). Therapeutic vaccines for chronic diseases: Successes and technical challenges. Philosophical Transactions of the Royal Society B: Biological Sciences, 366, 2815-2822.
122. Spohn, G., Jennings, G. T., Martina, B. E., Keller, I., Beck, M., Pumpens, P., et al. (2010). A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice. Virology Journal, 7, 146.
123. Pastori, C., Tudor, D., Diomede, L., Drillet, A. S., Jegerlehner, A., Röhn, T. A., et al. (2012). Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41. Virology, 431, 1-11.
124. Smith, M. L., Lindbo, J. A., Dillard-Telm, S., Brosio, P. M., Lasnik, A. B., McCormick, A. A., et al. (2006). Modified Tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications. Virology, 348, 475-488.
125. Natilla, A., & Hammond, R. W. (2011). Maize rayado fino virus virus-like particles expressed in tobacco plants: A new platform for cysteine selective bioconjugation peptide display. Journal of Virological Methods, 178, 209-215.
126. Minten, I. J., Claessen, V. I., Blank, K., Rowan, A. E., Nolte, R. J. M., & Cornelissen, J. J. (2011). Catalytic capsids: The art of confinement. Chemical Science, 2, 358-362.
127. Minten, I. J., Hendriks, L. J., Nolte, R. J., & Cornelissen, J. J. (2009). Controlled encapsulation of multiple proteins in virus capsids. Journal of the American Chemical Society, 131, 17771-17773.
128. Ohtake, N., Niikura, K., Suzuki, T., Nagakawa, K., Mikuni, S., Matsuo, Y., et al. (2010). Low pH-triggered model drug molecule release from virus-like particles. ChemBioChem, 11, 959-962.
129. Walker, A., Skamel, C., & Nassal, M. (2011). SplitCore: An exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure. Scientific Reports, 1, 5.
130. Werner, S., Marillonnet, S., Hause, G., Klimyuk, V., & Gleba, Y. (2006). Immunoabsorbent nanoparticles based on a tobamovirus displaying protein A. Proceedings of the National Academy of Science of the United States of America, 103, 17678-17683. (Pubitemid 44852219)
131. Gleiter, S., & Lilie, H. (2005). Cell-type specific targeting and gene expression using a variant of polyoma VP1 virus-like particles. Biological Chemistry, 384, 247-255.
132. Park, J. S., Cho, M. K., Lee, E. J., Ahn, K. Y., Lee, K. E., Jung, J. H., et al. (2009). A highly sensitive and selective diagnostic assay based on virus nanoparticles. Nature Nanotechnology, 4, 259-264.
133. Cardinale, D., Carette, N., & Michon, T. (2012). Virus scaffolds as enzyme nano-carriers. Trends in Biotechnology, 30, 369-376.
134. Mokili, J. L., Rohwer, F., & Dutilh, B. E. (2012). Metagenomics and future perspectives in virus discovery. Current Opinion in Virology, 2, 63-77.
135. Janssens, M. E., Geysen, D., Broos, K., De Goeyse, I., Robbens, J., Van Petegem, F., et al. (2010). Folding properties of the hepatitis B core as a carrier protein for vaccination research. Amino Acids, 38, 1617-1626.
136. Hulo, C., de Castro, E., Masson, P., Bougueleret, L., Bairoch, A., Xenarios, I., et al. (2011). ViralZone: A knowledge resource to understand virus diversity. Nucleic Acids Research, 39, D576-D582.
137. Tremblay, M. H., Majeau, N., Gagné, M. E., Lecours, K., Morin, H., Duvignaud, J. B., et al. (2006). Effect of mutations K97A and E128A on RNA binding and self assembly of papaya mosaic potexvirus coat protein. FEBS Journal, 273, 14-25.
138. Caballero, S., Guix, S., Ribes, E., Bosch, A., & Pintó, R. M. (2004). Structural requirements of astrovirus virus-like particles assembled in insect cells. Journal of Virology, 78, 13285-13292. (Pubitemid 39507833)
139. Farnós, O., Fernández, E., Chiong, M., Parra, F., Joglar, M., Méndez, L., et al. (2009). Biochemical and structural characterization of RHDV capsid protein variants produced in Pichia pastoris: Advantages for immunization strategies and vaccine implementation. Antiviral Research, 81, 25-36.
140. Lu, X. Y., Chen, Y., Bai, B. K., Hu, H., Tao, L., Yang, J., et al. (2007). Immune responses against SARS CoV induced by virus-like particles in mice. Immunology, 122, 496-502. (Pubitemid 350075956)
141. Ohtaki, N., Takahashi, H., Kaneko, K., Gomi, Y., Ishikawa, T., Higashi, Y., et al. (2010). Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate. Vaccine, 28, 6588-6596.
142. Li, T. C., Yamakawa, Y., Suzuki, K., Tatsumi, M., Razak, M. A., Uchida, T., et al. (1997). Expression and self-assembly of empty virus-like particles of hepatitis E virus. Journal of Virology, 71, 7207-7213. (Pubitemid 27391654)
143. Cielens, I., Ose, V., Petrovskis, I., Strelnikova, A., Renhofa, R., Kozlovska, T., et al. (2000). Mutilation of RNA phage Qbeta virus-like particles: From icosahedrons to rods. FEBS Letters, 482, 261-264.
144. Lamb, J. W., Duncan, G. H., Reavy, B., Gildow, F. E., Mayo, M. A., & Hay, R. T. (1996). Assembly of virus-like particles in insect cells infected with a baculovirus containing a modified coat protein gene of potato leafroll luteovirus. Journal of General Virology, 77, 1349-1358. (Pubitemid 26248646)
145. Schneemann, A., Dasgupta, R., Johnson, J. E., & Rueckert, R. R. (1993). Use of recombinant baculoviruses in synthesis of morphologically distinct viruslike particles of flock house virus, a nodavirus. Journal of Virology, 67, 2756-2763. (Pubitemid 23118874)
146. Luo, L., Li, Y., & Kang, C. Y. (1990). Expression of gag precursor protein and secretion of virus-like gag particles of HIV-2 from recombinant baculovirus-infected insect cells. Virology, 179, 874-880.
147. Shanks, M., & Lomonossoff, G. P. (2000). Co-expression of the capsid proteins of Cowpea mosaic virus in insect cells leads to the formation of virus-like particles. Journal of General Virology, 81, 3093-3097. (Pubitemid 32000656)
148. Pringle, F. M., Kalmakoff, J., & Ward, V. K. (2001). Analysis of the capsid processing strategy of Thosea asigna virus using baculovirus expression of virus-like particles. Journal of General Virology, 82, 259-266. (Pubitemid 32045814)
149. Sastri, M., Kekuuda, R., Gopinath, K., Ranjith Kumar, C. T., Jagath, J. R., & Savithri, H. S. (1997). Assembly of physalis mottle virus capsid protein in Escherichia coli and the role of amino and carboxy termini in the formation of the icosahedral particles. Journal of Molecular Biology, 272, 541-552. (Pubitemid 27429841)
150. Li, C., Liu, F., Liang, M., Zhang, Q., Wang, X., Wang, T., et al. (2010). Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice. Vaccine, 28, 4294-4300.
151. Warfield, K. L., Bosio, C. M., Welcher, B. C., Deal, E. M., Mohamadzadeh, M., Schmaljohn, A., et al. (2003). Ebola virus-like particles protect from lethal Ebola virus infection. Proceedings of the National Academy of Science of the United States of America, 100, 15889-15894. (Pubitemid 38021085)
152. Walpita, P., Barr, J., Sherman, M., Basler, C. F., & Wang, L. (2011). Vaccine potential of Nipah virus-like particles. PLoS ONE, 6(4), e18437.
153. Fernández-Arias, A., Risco, C., Martínez, S., Albar, J. P., & Rodríguez, J. F. (1998). Expression of ORF A1 of infectious bursal disease virus results in the formation of virus-like particles. Journal of General Virology, 79, 1047-1054. (Pubitemid 28203845)
154. Fender, P., Ruigrok, R. W., Gout, E., Buffet, S., & Chroboczek, J. (1997). Adenovirus dodecahedron, a new vector for human gene transfer. Nature Biotechnology, 15, 52-56. (Pubitemid 27024148)
155. Yin, S., Sun, S., Yang, S., Shang, Y., Cai, X., & Liu, X. (2010). Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli. Virology Journal, 7, 166.
156. Newcomb, W. W., Homa, F. L., Thomsen, D. R., Trus, B. L., Cheng, N., Steven, A., et al. (1999). Assembly of the herpes simplex virus procapsid from purified components and identification of small complexes containing the major capsid and scaffolding proteins. Journal of Virology, 73, 4239-4250. (Pubitemid 29189869)
157. Saliki, J. T., Mizak, B., Flore, H. P., Gettig, R. R., Burand, J. P., Carmichael, L. E., et al. (1992). Canine parvovirus empty capsids produced by expression in a baculovirus vector: Use in analysis of viral properties and immunization of dogs. Journal of General Virology, 73, 369-374.
158. Sasnauskas, K., Bulavaite, A., Hale, A., Jin, L., Knowles, W. A., Gedvilaite, A., et al. (2002). Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae. Intervirology, 45, 308-317. (Pubitemid 36173440)